Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Type

Guidance programme

Guidance programme

HealthTech approach

HealthTech approach

Advice programme

Area of interest

Showing 191 to 200 of 334

TitleReference numberPublishedLast updated
Bevacizumab with carboplatin, gemcitabine and paclitaxel for treating the first recurrence of platinum-sensitive advanced ovarian cancer (terminated appraisal)TA560
Axumin for functional imaging of prostate cancer recurrenceMIB172
Electrically stimulated intravesical chemotherapy for non-muscle-invasive bladder cancerHTG499
Pancreatic cancerQS177
Oesophago-gastric cancerQS176
Vandetanib for treating medullary thyroid cancerTA550
Padeliporfin for untreated localised prostate cancerTA546
Intravesical microwave hyperthermia and chemotherapy for non-muscle-invasive bladder cancerHTG487
AlignRT in breast cancer radiotherapyMIB157
Lenvatinib and sorafenib for treating differentiated thyroid cancer after radioactive iodineTA535

Results per page

  1. 10
  2. 25
  3. 50
  4. All